No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:23085800-23114600 |
Enhancers |
Placenta |
Placenta
|
2 |
chr20:23093000-23103200 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
3 |
chr20:23097600-23110200 |
Weak transcription |
Pancreas |
Pancrea
|
4 |
chr20:23098000-23106000 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
5 |
chr20:23099600-23104600 |
Weak transcription |
Placenta Amnion |
Placenta Amnion
|
6 |
chr20:23099800-23105400 |
Weak transcription |
Gastric |
stomach
|
7 |
chr20:23100000-23103200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
8 |
chr20:23100000-23104000 |
Weak transcription |
GM12878-XiMat |
blood
|
9 |
chr20:23100200-23102800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
10 |
chr20:23100200-23103400 |
Weak transcription |
Primary B cells from cord blood |
blood
|
11 |
chr20:23100200-23111200 |
Enhancers |
Fetal Thymus |
thymus
|
12 |
chr20:23100400-23103200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
13 |
chr20:23100400-23106000 |
Weak transcription |
Colonic Mucosa |
Colon
|
14 |
chr20:23100600-23103200 |
Genic enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
15 |
chr20:23100600-23103200 |
Flanking Active TSS |
Dnd41 |
blood
|
16 |
chr20:23101000-23104400 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
17 |
chr20:23101000-23104600 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
18 |
chr20:23101200-23105400 |
Weak transcription |
Duodenum Smooth Muscle |
Duodenum
|
19 |
chr20:23101200-23106600 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
20 |
chr20:23101200-23109400 |
Weak transcription |
Liver |
Liver
|
21 |
chr20:23101400-23103200 |
Enhancers |
K562 |
blood
|
22 |
chr20:23101400-23105800 |
Weak transcription |
Skeletal Muscle Female |
skeletal muscle
|
23 |
chr20:23101400-23106000 |
Weak transcription |
Adipose Nuclei |
Adipose
|
24 |
chr20:23101600-23103200 |
Enhancers |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
25 |
chr20:23101600-23103200 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
26 |
chr20:23101600-23104600 |
Weak transcription |
Skeletal Muscle Male |
skeletal muscle
|
27 |
chr20:23101800-23106000 |
Weak transcription |
Left Ventricle |
heart
|
28 |
chr20:23101800-23109200 |
Weak transcription |
Right Ventricle |
heart
|
29 |
chr20:23102000-23104600 |
Weak transcription |
Esophagus |
oesophagus
|
30 |
chr20:23102000-23105800 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
31 |
chr20:23102000-23105800 |
Weak transcription |
Lung |
lung
|
32 |
chr20:23102000-23106200 |
Weak transcription |
Right Atrium |
heart
|
33 |
chr20:23102000-23106600 |
Weak transcription |
Spleen |
Spleen
|
34 |
chr20:23102000-23114000 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
35 |
chr20:23102600-23103200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|